ArticleJournal of complementary & integrative medicine2025
Navigating complementary and alternative medicine use, medication adherence, and herb-drug interaction risks among gout patients: a multicenter cross-sectional study in indonesia.
Article in Journal of complementary & integrative medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe use of complementary and alternative medicine (CAM) is increasing worldwide, specifically among gout patients, due to the perceived safety, low cost, and accessibility, but data on the usage remain limited. Therefore, this study aimed to assess the prevalence of CAM use, the predictors associated with CAM use, the impact on medication adherence, and the potential herb-drug interactions among gout patients.
methodsThis cross-sectional study was conducted from June to November 2024 across all 47 community health centers in Makassar City, Indonesia. The entire respondents were patients aged 18 years and older diagnosed with gout. Eligible respondents were recruited through direct questionnaire distribution, collecting data on socio-demographics, CAM and conventional medicine use, CAM perceptions, and medication adherence, while potential herb-drug interactions were assessed using the UpToDate database.
resultsAmong the 430 respondents, 52.8 % reported using CAM, with herbal medicine being the most frequently used option. CAM use was significantly associated with prior experience (p<0.001) and influence from family or friends (p<0.001). A significant association was also found between CAM use and medication adherence (p<0.001), with a higher proportion of non-CAM users exhibiting high adherence (76.8 vs. 7.9 %) and a higher proportion of CAM users demonstrating poor adherence (8.4 vs. 0.5 %). Four potential herb-drug interactions were identified, namely ginger-aspirin (n=2), ginger-glibenclamide (n=1), honey-warfarin (n=1), and garlic-aspirin (n=1), suggesting a need for clinical monitoring.
conclusionsThe frequent use of CAM among gout patients highlights the crucial role of healthcare practitioners in educating patients about safety, efficacy, and potential interactions. It also underscores the need for strategies to address medication non-adherence associated with CAM use and to monitor herb-drug interactions in clinical settings.
Indexed as
Identifiers
41347947What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.